Researchers, drug company employees, and government officials are meeting this week in Maryland to discuss how erectile dysfunction drugs may be linked with HIV infections and other sexually transmitted diseases, particularly among gay and bisexual men, The Boston Globe reports.
Studies have shown that gay men who use erectile dysfunction drugs like Viagra, Levitra, and Cialis are much more likely to practice unsafe sex and to be infected with HIV or another STD. A study conducted in San Francisco showed that 31% of a group of gay and bisexual men reported using Viagra without medical supervision. That study also showed Viagra use was linked with higher rates of risky sexual behavior and STDs. Another study shows that recreational Viagra users were twice as likely as nonusers to be HIV-positive.
Many gay and bisexual men also use erectile dysfunction drugs in combination with illegal club drugs like crystal methamphetamine or ecstasy to allow them to more easily engage in sex, often with multiple partners, researchers say.
Because of such study data, Jeffrey Klausner of the San Francisco Department of Public Health is calling on drug companies to curb free samples and limit refills of the drugs. He also has petitioned the Food and Drug Administration to classify the drugs as controlled substances, which he believes will help cut down on illegal distribution of the medications, and is calling for the drugs’ makers to conduct educational programs for health care providers and consumers to highlight the links between the drugs and risky sexual behavior. (Advocate.com)
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
Be the first to comment on this story.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.